Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nammi Therapeutics Inc
Nammi Therapeutics Inc
OncoC4, Inc.
Compass Therapeutics
Sotio Biotech Inc.
National Cancer Institute (NCI)
Exelixis
Baylor College of Medicine
ViroMissile, Inc.
Seattle Children's Hospital
St. Jude Children's Research Hospital
Jonsson Comprehensive Cancer Center
MacroGenics
City of Hope Medical Center
SAPU NANO (US) LLC
M.D. Anderson Cancer Center
Degron Therapeutics Co.
NeoTX Therapeutics Ltd.
AccSalus Biosciences, Inc.
West China Hospital
Coherus Oncology, Inc.
St. Jude Children's Research Hospital
Baylor College of Medicine
HiFiBiO Therapeutics
Pfizer
Exelixis
Jonsson Comprehensive Cancer Center
University of Virginia
Incyte Corporation
Incyte Corporation
Bristol-Myers Squibb
LaunXP Biomedical Co., Ltd.
Incyte Corporation
Children's National Research Institute
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
Molecular Templates, Inc.
Xencor, Inc.
Pliant Therapeutics, Inc.
National Cancer Institute (NCI)
Atreca, Inc.
University of Florida
Lebanese University
Fate Therapeutics
Children's National Research Institute
Tempest Therapeutics
Fate Therapeutics
Xencor, Inc.
Xencor, Inc.
Gossamer Bio Inc.
Pfizer